Magenta Therapeutics

Acquired

2025년 최신 피망머니상 시세표 총정리

Cambridge, United States · Founded 2016 · $150.5M raised

Headquarters
Cambridge
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$150.5M
Last Round
$52.0M Series CApr 2018
Rounds
3
Acquisition Date
May 2023

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Magenta Therapeutics was a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplantation to patients with blood cancers, autoimmune diseases, and genetic disorders. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company merged with Dianthus Therapeutics in 2023.

Summary

Magenta Therapeutics is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $150.5M in total across 3 rounds, most recently a $52.0M Series C round in Apr 2018. Investors include Atlas Venture, Third Rock Ventures and Casdin Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

MergerReverse Merger with Dianthus TherapeuticsMay 2023

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Magenta Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/magenta-therapeutics"><img src="https://indexed.vc/api/badge/company/magenta-therapeutics" alt="Magenta Therapeutics on Indexed.vc" width="260" height="76" /></a>